The Relation between Surviving Gene Expression and Urinary Bladder Cancer Disease

Journal article


Arafat, W, El Ashry, MS, Abd Alrazek, MAA, Matta, CA, El Aleem, EA, Kamel, E, Hussein, M, Ezzat, G and Samir, M (2017). The Relation between Surviving Gene Expression and Urinary Bladder Cancer Disease. Hospice and Palliative Medicine International Journal. 1 (2). https://doi.org/10.15406/hpmij.2017.01.00007
AuthorsArafat, W, El Ashry, MS, Abd Alrazek, MAA, Matta, CA, El Aleem, EA, Kamel, E, Hussein, M, Ezzat, G and Samir, M
Abstract

Purpose: The aim of this study is to investigate the expression of survivin gene in patients suffering from urinary bladder cancer, thus contributing to further understanding of the molecular etiology of the disease by assessment of Survivin gene expression on both RNA and protein levels in urinary bladder tissue samples and Correlate between its expression and pathological prognostic parameters of patients with urinary bladder cancer risk.
Methods: In the present study 26 cases of urinary bladder cancer and 26 cases of normal tissues far from tumor sites in the urinary bladder of the same patients (as control samples) were collected, also 10 paraffin-embedded tissue samples from consecutive of archival bladder specimens patients and 10 tissue samples that of healthy tissue from the same individual as control group were collected for immunohistochemical detection of survivin protein and real time PCR for survivin mRNA detection.
Results: In normal tissues of control samples no expression for survivin gene has been noticed. However, in patients affected with bladder cancer the survivin expression was highly increased by increasing degree of tumor malignancy as indicated by real time PCR for survivin mRNA and immunohistochemistry for survivin protein.
Conclusion: From this study, it is concluded that survivin protein was not expressed in normal bladder urothelium but was present in a high percentage in tissue samples of patients suffering from bladder cancer and its expression is associated with disease recurrence, tumor grade, progression and mortality.

Year2017
JournalHospice and Palliative Medicine International Journal
Journal citation1 (2)
PublisherMedCrave
ISSN2576-4497
Digital Object Identifier (DOI)https://doi.org/10.15406/hpmij.2017.01.00007
Publication dates
Print14 Jun 2017
Publication process dates
Deposited12 Dec 2018
Accepted14 Jun 2017
Publisher's version
License
File Access Level
Open
Permalink -

https://openresearch.lsbu.ac.uk/item/86z0y

Download files


Publisher's version
HPMIJ-01-00007.pdf
License: CC BY 4.0
File access level: Open

  • 85
    total views
  • 301
    total downloads
  • 4
    views this month
  • 0
    downloads this month

Export as